WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'9401 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 16'4631 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 122'332  120'847  119'361  117'886  116'423  103'874  86'077  70'353 
Births 2'252  2'269  2'287  2'306  2'325  2'503  2'438  2'375 
Surviving infants 2'220  2'236  2'253  2'270  2'288  2'443  2'350  2'253 
Pop. less than 5 years 11'292  11'405  11'501  11'573  11'643  12'293  11'373  11'237 
Pop. less than 15 years 34'839  35'068  35'264  35'419  35'518  35'399  33'126  31'439 
Female 15-49 years 34'007  33'616  33'209  32'796  32'403  28'614  21'572  15'689 

Number of reported case

(Click for retrospective incidence data for Mexico)
Diphtheria
Japanese encephalitis
Measles 30  68'782  29'730 
Mumps 5'683  2'685  27'403 
Pertussis 961  978  252  559  53  1'078  5'539 
Polio* 682 
Rubella 11'751 
Rubella (CRS)
Tetanus (neonatal) 145 
Tetanus (total) 20  28  23  39  103  381  363 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mexico)
Vaccine year result method % card seen                                                
BCG 1986  73  DHS     91  99  99  98  99  100  67  48 
DTP1 1986  77  DHS     90  100  96  98  99 
DTP3 1986  34  DHS     83  99  97  95  95  97  53  44 
HepB_BD          82  98  84 
HepB3          79  99  98  93  95  97 
Hib3          83  99  97  95  95  97 
JapEnc         
MCV 1986  59  DHS     89  99  98  95  96  96  75  35 
MCV2          76  92  97  91  92  98 
PCV1          88  99  97  93 
PCV3          84  99  98  92  46 
Pol3 1986  57  DHS     83  99  97  95  95  97  66  91 
Rota1          90  99  96  97 
Rota_last          81  99  98  90  93 
Rubella1          89  99  98  95  96 
TT2plus          99  78 
PAB         
VAD1          94  94  95  94  100 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mexico)
BCG 91  99  99  98  99  99  67  48 
DTP1 90  99  99  96  98  99  77  69 
DTP3 83  99  97  95  95  97  53  44 
HepB3 82  99  98  93  95  97 
HepB_BD 82  90  98  84 
Hib3 83  99  97  95  95  97 
MCV 89  99  98  95  96  96  75  35 
MCV2 76  92  97  91  92  98 
PAB 88  88  88  88  87  81  59 
PCV3 84  99  98  92  46 
Pol3 83  99  97  95  95  97  66  91 
Rota_last 81  99  98  90  93 

Number of districts in the country 2'440  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 18 months;
DTwP 4 years; Yes
HIB 2, 4, 6, 18 months;
HPV 9 years; Yes or 11 years
HepA 1 year;
HepB birth; 2, 6 months; Yes and > 11 years
IPV 2, 4, 6, 18 months;
Influenza 6-35 months; >50 years Yes and PW
MMR 1, 6 years; Yes
MR 11-12 years; Yes Not having received 2nd dose of MMR
OPV > 6 months; < 5 Years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >=50 years;
Rotavirus 2, 4, 6 months; Yes
Td 11-12 years (x2); >12 years (x4); Yes and pregnant women
Tdap pregnant women; Yes
Varicella 1 year;
VitaminA 6-59 months (x6); Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2012-2018  2007-2012    2007-2010  2007-2012  2007-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 32  236      236  236  236 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 2'440  2'432  2'456  2'438  2'438  2'438  2'474 
Nº districts with DTP3 coverage >=80% number 2'162  2'162  2'195  28 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  89  90 
Nº districts with measles (MCV1) coverage >=95% number   2'031      2'031  2'053   
% of districts with MCV1 coverage >=95% From 0 to 100%   84      83  84   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.